Abstract
Autoimmune diseases, known as immune-mediated diseases, occur when the
immune system targets and attacks its own cells. In the field of medicine, there is a
wide range of autoimmune conditions, including insulin-dependent Type 1 Diabetes
Mellitus T1DM, Type 2 Diabetes Mellitus T2DM, Rheumatoid Arthritis RA, and
Thyroiditis. These diseases can either be primary, with no clearly defined cause, or
secondary, triggered by factors such as medications, infections, or malignancies.
Animal models have proven invaluable for gaining insights into the underlying
pathologies, causes, and specific signaling pathways associated with human
autoimmune diseases. This is because these animal models share physiological
similarities with humans and have shorter lifespans, allowing researchers to observe the
entire disease progression. To replicate the complexity of autoimmune diseases in
experimental models, researchers utilize various animal species, including monkeys,
rabbits, rats, and mice. These methods can be broadly categorized into three strategies:
immunization with autoantigens, transfer of autoimmunity, and induction through
environmental factors. Numerous studies have been conducted using animal models to
investigate the immunological pathophysiology of RA and assess the effectiveness of
anti-rheumatic medications. There are several mouse models designed to mimic RAlike disease, each focusing on specific aspects of the condition. While animal models
come with limitations, such as incomplete disease manifestations and limited genetic
similarity to humans due to human genetic diversity, they remain an essential tool for
understanding the pathogenesis of autoimmune diseases. Among the various animal
models used in research, mice and other rodents like rats and hamsters account for over
90% of the total number of animals employed in these studies.